{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:41Z","timestamp":1786991621689,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jceh.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T12:53:10Z","timestamp":1518785590000},"page":"29-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker"],"prefix":"10.1016","volume":"9","author":[{"given":"\u00d6zlem","family":"Akdo\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015feg\u00fcl","family":"Atak Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-4105","authenticated-orcid":false,"given":"Zeynep","family":"G\u00f6k Sargin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemile","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcldal","family":"Esenda\u011fli Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seren","family":"\u00d6zenirler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2018.02.001_bib0170","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2018.02.001_bib0175","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4254\/wjh.v7.i18.2155","article-title":"Advances in hepatocellular carcinoma: nonalcoholic steatohepatitis-related hepatocellular carcinoma","volume":"7","author":"Khan","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jceh.2018.02.001_bib0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0190","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0195","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jceh.2018.02.001_bib0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0009-9120(90)90601-P","article-title":"Biomedical and biochemical aspects of the plasminogen activation system","volume":"23","author":"Mayer","year":"1990","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jceh.2018.02.001_bib0205","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: a versatile signaling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0033-1334483","article-title":"Plasminogen receptors: the first quarter century","volume":"39","author":"Miles","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jceh.2018.02.001_bib0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7150\/thno.4218","article-title":"Role of urokinase receptor in tumor progression and development","volume":"3","author":"Noh","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.jceh.2018.02.001_bib0220","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728222.2016.1113260","article-title":"The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies","volume":"20","author":"Su","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jceh.2018.02.001_bib0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0039-6060(98)70078-9","article-title":"The plasminogen activator\/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings","volume":"124","author":"Friess","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.jceh.2018.02.001_bib0230","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0016-5085(97)70186-0","article-title":"Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis","volume":"113","author":"Friess","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2018.02.001_bib0235","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajem.2015.11.004","article-title":"Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis","volume":"34","author":"Zeng","year":"2016","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jceh.2018.02.001_bib0240","doi-asserted-by":"crossref","first-page":"375702","DOI":"10.1155\/2014\/375702","article-title":"Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study","volume":"2014","author":"Siahanidou","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jceh.2018.02.001_bib0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/cclm-2012-0221","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission","volume":"51","author":"Toldi","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jceh.2018.02.001_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-009-9152-0","article-title":"Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis","volume":"33","author":"Pliyev","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.jceh.2018.02.001_bib0255","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1373\/clinchem.2013.203778","article-title":"Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain","volume":"59","author":"Lyngb\u00e6k","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.jceh.2018.02.001_bib0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00508-015-0886-4","article-title":"Serum soluble urokinase-type plasminogen activator receptor and interferon-\u03b3-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B","volume":"128","author":"Sevgi","year":"2016","journal-title":"Wien KlinWochenschr"},{"key":"10.1016\/j.jceh.2018.02.001_bib0265","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MCG.0b013e31822da19d","article-title":"Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection","volume":"46","author":"Berres","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0270","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.thromres.2008.06.013","article-title":"Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B","volume":"123","author":"Zhou","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.jceh.2018.02.001_bib0275","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.4049\/jimmunol.1302864","article-title":"Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion","volume":"192","author":"Fleetwood","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0280","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1083\/jcb.110.4.1361","article-title":"Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin","volume":"110","author":"Lyons","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0285","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/092986708783955455","article-title":"Fibrinolysis: the key to new pathogenetic mechanisms","volume":"15","author":"Zorio","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jceh.2018.02.001_bib0290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2001\/870205","article-title":"Liver fibrosis and altered matrix synthesis","volume":"15","author":"Neubauer","year":"2001","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0295","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2018.02.001_bib0300","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-17552","article-title":"Extracellular matrix degradation and the role of hepatic stellate cells","volume":"21","author":"Benyon","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2018.02.001_bib0305","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.1996.v111.pm8780581","article-title":"Gene expression and regulation of plasminogen activator inhibitor type 1 in hepatic stellate cells of rat liver","volume":"111","author":"Knittel","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2018.02.001_bib0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.1992.tb51591.x","article-title":"The urokinase receptor: involvement in cell surface proteolysis and cancer invasion","volume":"667","author":"Ellis","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jceh.2018.02.001_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1992.tb51590.x","article-title":"The role of plasminogen activators in the regulation of connective tissue metalloproteinases","volume":"667","author":"Murphy","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jceh.2018.02.001_bib0320","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0168-8278(99)80351-1","article-title":"Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells","volume":"31","author":"Zhang","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0325","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0002-9440(10)63069-6","article-title":"Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury","volume":"159","author":"Pohl","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jceh.2018.02.001_bib0330","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/j.1538-7836.2007.02653.x","article-title":"Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice","volume":"5","author":"J\u00f6gi","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368831830032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368831830032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:10Z","timestamp":1760853910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S097368831830032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S097368831830032X"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2018.02.001","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 INASL.","name":"copyright","label":"Copyright"}]}}